| Application no. and date | 07761873.4 (espacenet) (Federated) (European Patent Register), 20070504 | | Patent/reg. no. and date | DK/EP 2024375, 20110309 | | Publication date | 20090218 | | Priority no. and date | US 801125 P, 20060517, US 802005 P, 20060519, US 852084 P, 20061016, US 894757 P, 20070314 | | EP pub. no. and date |
EP 2024375 20090218 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Holdings Ireland Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | 09315-4 | | Inventor | BENDER, John A., c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492, US,
DING, Min, c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492, US,
GENTLES, Robert G., c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492, US,
HEWAWASAM, Piyasena, c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/55 (2006.01) , A61P 31/12 (2006.01) , C07D 519/00 (2006.01) | | Title | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | | Int. application no. | US2007068209 | | Int. publication no. | WO2007136982 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
